ADMA Biologics, Inc. (ADMA) shares price almost doubled since company announced that the FDA approved its Asceniv, intravenous immunoglobulin product for the treatment of primary humoral immunodeficiency disease (PIDD), in adults and adolescents ages from 12 to 17. PIDD is a collective term for numerous diseases that occur due to defects in the body’s immune […]
Chart/Volume Play – be sure that you read Curis’s PR beforehands: Curis, Inc. (CRIS), a biotechnology company, announced on September 14th, 2014 the pricing of an underwritten public offering of 20,000,000 shares of its common stock (the “Offering”). The Offering is expected to close on or about September 18, 2017, subject to customary closing conditions. […]
“Must-Read” review from BiotechIntel Novo Nordisk – the world’s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment. Over $100,000,000 has been invested in developing this super-drug that threatens to make […]
Congratulations to the PennyStockHaven’s subscribers with gains of over 300% on the MRI Interventions, Inc. (MRIC). MRIC has been profiled at $1+ and topped $5 in a month time-frame. Be ready for the new investment opportunity pick to be delivered in your inbox this Sunday, July 8th, 2012:
